NCT01823198
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Acute Myeloid Leukemia in Remission
Explore clinical trials studying Acute Myeloid Leukemia in Remission. Study availability and eligibility vary by location and protocol.
26 public trials
7 recruiting studies
Acute Myeloid Leukemia in Remission trial results
NCT04712942
- Conditions
- Acute Myeloid Leukemia in Remission, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- Medizinische Klinik IV - Hämatologie und Onkologie, Universitätsklinikum Aachen Aachen, Germany
- Zentrum Hämatologie, Onkologie, Palliativmedizin, Helios Klinikum Berlin-Buch GmbH Berlin, Germany
- Klinik für Innere Medizin III, Hämatologie, Onkologie, Stammzelltransplantation, Klinikum Chemnitz gGmbH Chemnitz, Germany
- Hämatologie/Internistische Onkologie, Onkologische Tagesklinik Cottbus, Germany
NCT00796068
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +25 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- Oregon Health and Science University Portland, Oregon, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02083250
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, +19 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +22 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- University of Colorado Denver, Colorado, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT04617145
- Conditions
- Acute Myeloid Leukemia in Remission
- Locations
-
- Faculty of Physical Therapy Giza, Cairo Governorate, Egypt
NCT00453388
- Conditions
- Acute Myeloid Leukemia in Remission, Anemia, Anemia, Aplastic, +14 more
- Locations
-
- Children's Hospital and Research Center at Oakland Oakland, California, United States
- Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States
NCT00075478
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, +48 more
- Locations
-
- OHSU Cancer Institute-Southern Region Medford, Oregon, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
NCT01413568
- Conditions
- Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission, Blood Protein Disorders, +36 more
- Locations
-
- University of Kansas Cancer Center Kansas City, Kansas, United States
- Washington University School of Medicine St Louis, Missouri, United States
Active, Not Recruiting
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
NCT02506933
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +43 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- M D Anderson Cancer Center Houston, Texas, United States